메뉴 건너뛰기




Volumn 26, Issue 8, 2012, Pages

The natural history of hormone receptor positive breast cancer: Attempting to decipher an intriguing concept

Author keywords

[No Author keywords available]

Indexed keywords

ANASTROZOLE; AROMATASE INHIBITOR; ESTROGEN RECEPTOR; KI 67 ANTIGEN; LETROZOLE; TAMOXIFEN;

EID: 84874644584     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note
Times cited : (5)

References (9)
  • 1
    • 84862584058 scopus 로고    scopus 로고
    • Whole-genome analysis informs breast cancer response to aromatase inhibition
    • Ellis MJ, Ding L, Shen D, et al. Whole-genome analysis informs breast cancer response to aromatase inhibition. Nature. 2012;486: 353-60.
    • (2012) Nature , vol.486 , pp. 353-360
    • Ellis, M.J.1    Ding, L.2    Shen, D.3
  • 2
    • 33846965616 scopus 로고    scopus 로고
    • Prognostic value of Ki67 expression after short-term presurgical endocrine therapy for primary breast cancer
    • Dowsett M, Smith IE, Ebbs SR, et al. Prognostic value of Ki67 expression after short-term presurgical endocrine therapy for primary breast cancer. J Natl Cancer Inst. 2007;99:167-70.
    • (2007) J Natl Cancer Inst. , vol.99 , pp. 167-170
    • Dowsett, M.1    Smith, I.E.2    Ebbs, S.R.3
  • 3
    • 64949102825 scopus 로고    scopus 로고
    • Improved surgical outcomes for breast cancer patients receiving neoadjuvant aromatase inhibitor therapy: Results from a multicenter phase II trial
    • discussion 915-16
    • Olson JA, Jr., Budd GT, Carey LA, et al. Improved surgical outcomes for breast cancer patients receiving neoadjuvant aromatase inhibitor therapy: results from a multicenter phase II trial. J Am Coll Surg. 2009;208:906-14; discussion 915-16.
    • (2009) J Am Coll Surg. , vol.208 , pp. 906-914
    • Olson Jr., J.A.1    Budd, G.T.2    Carey, L.A.3
  • 4
    • 19944429855 scopus 로고    scopus 로고
    • Short-term changes in Ki-67 during neoadjuvant treatment of primary breast cancer with anastrozole or tamoxifen alone or combined correlate with recurrence-free survival
    • Dowsett M, Smith IE, Ebbs SR, et al. Short-term changes in Ki-67 during neoadjuvant treatment of primary breast cancer with anastrozole or tamoxifen alone or combined correlate with recurrence-free survival. Clin Cancer Res. 2005;11:951s-8s.
    • (2005) Clin Cancer Res. , vol.11
    • Dowsett, M.1    Smith, I.E.2    Ebbs, S.R.3
  • 5
    • 53249154813 scopus 로고    scopus 로고
    • Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics
    • Ellis MJ, Tao Y, Luo J, et al. Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics. J Natl Cancer Inst. 2008;100:1380-8.
    • (2008) J Natl Cancer Inst. , vol.100 , pp. 1380-1388
    • Ellis, M.J.1    Tao, Y.2    Luo, J.3
  • 6
    • 78349309809 scopus 로고    scopus 로고
    • Tumor Ki67 proliferation index within 4 weeks of initiating neoadjuvant endocrine therapy for early identification of non-responders
    • abstr 78
    • Ellis MJ, Luo J, Tao Y, et al. Tumor Ki67 proliferation index within 4 weeks of initiating neoadjuvant endocrine therapy for early identification of non-responders. Cancer Res. 2009;69(24 Suppl): abstr 78.
    • (2009) Cancer Res. , vol.69 , Issue.24 SUPPL.
    • Ellis, M.J.1    Luo, J.2    Tao, Y.3
  • 7
    • 79959268722 scopus 로고    scopus 로고
    • Randomized phase II neoadjuvant comparison between letrozole, anastrozole, and exemestane for postmenopausal women with estrogen receptor-rich stage 2 to 3 breast cancer: Clinical and biomarker outcomes and predictive value of the baseline PAM50-based intrinsic subtype--ACOSOG Z1031
    • Ellis MJ, Suman VJ, Hoog J, et al. Randomized phase II neoadjuvant comparison between letrozole, anastrozole, and exemestane for postmenopausal women with estrogen receptor-rich stage 2 to 3 breast cancer: clinical and biomarker outcomes and predictive value of the baseline PAM50-based intrinsic subtype--ACOSOG Z1031. J Clin Oncol. 2011;29:2342-9.
    • (2011) J Clin Oncol. , vol.29 , pp. 2342-2349
    • Ellis, M.J.1    Suman, V.J.2    Hoog, J.3
  • 8
    • 79958770468 scopus 로고    scopus 로고
    • Importance of PI3-kinase pathway in response/resistance to aromatase inhibitors
    • Ma CX, Crowder RJ, Ellis MJ. Importance of PI3-kinase pathway in response/resistance to aromatase inhibitors. Steroids. 2011;76:750-2.
    • (2011) Steroids , vol.76 , pp. 750-752
    • Ma, C.X.1    Crowder, R.J.2    Ellis, M.J.3
  • 9
    • 81555208345 scopus 로고    scopus 로고
    • Assessment of Ki67 in breast cancer: Recommendations from the International Ki67 Breast Working Goup
    • Dowsett M, Nielsen TO, A'Hern R, et al. Assessment of Ki67 in breast cancer: recommendations from the International Ki67 Breast Working Goup. J Natl Cancer Inst. 2011;103:1-9.
    • (2011) J Natl Cancer Inst. , vol.103 , pp. 1-9
    • Dowsett, M.1    Nielsen, T.O.2    A'Hern, R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.